APAR Industries (APARINDS) is currently trading between ₹8,083 and ₹8,620 per share as of June 26, 2025. The stock is down about 31% from its 52-week high of ₹11,779.90 (reached in January 2025), but it remains 85% above its 52-week low of ₹4,308.05 (from April 2025). Over the past six and twelve months, APARINDS has delivered negative returns of -22.68% and -16.58%, respectively, reflecting a significant correction after a strong rally earlier in the year.
Valuation-wise, the stock has a price-to-earnings (P/E) ratio of around 39, which is lower than the industry average of 59.33 but still considered high. The price-to-book (P/B) ratio stands at 7.21, and the dividend yield is modest at about 0.63%. The company’s earnings per share (EPS) for the trailing twelve months is ₹204.46.
Financially, APARINDS reported revenue of ₹185.81 billion and a net profit of ₹8.21 billion for the trailing twelve months, with a net profit margin of roughly 4.4%. The company maintains a low debt-to-equity ratio of 0.13 and a strong return on equity (ROE) of 18.24%. Growth remains robust, with standalone net sales up 17.87% year-on-year in March 2025 and quarterly net profit rising by 2.45% year-on-year.
Analysts forecast an average one-year target price of ₹9,122, with estimates ranging from ₹6,672 to ₹11,025, suggesting about 8% upside from current levels. Over the next three years, revenue and net income are expected to grow at a compound annual rate of 14–17% and 15–18%, respectively, while EPS is projected to increase by about 15.3% per year. ROE is expected to reach around 20% within three years.
Key strengths for APARINDS include strong revenue and earnings growth, high promoter holding (57.77%), low leverage, and a robust ROE. The main risks are its high valuation, which may limit near-term upside, and the recent negative returns, which indicate some profit-taking or correction after earlier gains.
In summary, APARINDS remains fundamentally strong with solid growth prospects, but investors should be mindful of its premium valuation and recent price volatility when considering entry.
Valuation-wise, the stock has a price-to-earnings (P/E) ratio of around 39, which is lower than the industry average of 59.33 but still considered high. The price-to-book (P/B) ratio stands at 7.21, and the dividend yield is modest at about 0.63%. The company’s earnings per share (EPS) for the trailing twelve months is ₹204.46.
Financially, APARINDS reported revenue of ₹185.81 billion and a net profit of ₹8.21 billion for the trailing twelve months, with a net profit margin of roughly 4.4%. The company maintains a low debt-to-equity ratio of 0.13 and a strong return on equity (ROE) of 18.24%. Growth remains robust, with standalone net sales up 17.87% year-on-year in March 2025 and quarterly net profit rising by 2.45% year-on-year.
Analysts forecast an average one-year target price of ₹9,122, with estimates ranging from ₹6,672 to ₹11,025, suggesting about 8% upside from current levels. Over the next three years, revenue and net income are expected to grow at a compound annual rate of 14–17% and 15–18%, respectively, while EPS is projected to increase by about 15.3% per year. ROE is expected to reach around 20% within three years.
Key strengths for APARINDS include strong revenue and earnings growth, high promoter holding (57.77%), low leverage, and a robust ROE. The main risks are its high valuation, which may limit near-term upside, and the recent negative returns, which indicate some profit-taking or correction after earlier gains.
In summary, APARINDS remains fundamentally strong with solid growth prospects, but investors should be mindful of its premium valuation and recent price volatility when considering entry.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.